Companies
CAS Institute of Botany
a 2026 breakthrough converted CO2 and water efficiently to energy under natural sunlight, advancing China's artificial-photosynthesis programme toward a usable solar-fuel device.
- Country
- China
Research
Artificial photosynthesis
Coverage
| CN | EU | IN | US | |
|---|---|---|---|---|
| biofuels-bioenergy | ✓ | ✓ | ✓ | ✓ |
Regulatorsusda-aphisepanea
Verifiable facts
| Fact | Value | Source |
|---|---|---|
| Affiliation | Institute of Botany, Chinese Academy of Sciences (IBCAS) | english.ib.cas.cn · ib.cas.cn |
| Research focus | solar energy bio-transformation, photosynthesis research, plant molecular physiology, vegetation and environmental change, biodiversity conservation | english.ib.cas.cn · ib.cas.cn · klpb.ibcas.ac.cn |
| Facility | Key Laboratory of Photobiology, State Key Laboratory of Plant Diversity and Specialty Crops, State Key Laboratory of Forage Breeding-by-Design and Utilization, Laboratory of Systematic & Evolutionary Botany, Laboratory of Vegetation & Environmental Change, Laboratory of Plant Molecular Physiology, Botanical Garden, Big Data and AI Biodiversity Conservation Research Center, Documentation Center, CAS Plant Science Data Center, herbarium | english.ib.cas.cn · ib.cas.cn · klpb.ibcas.ac.cn |
| Grant | 46 ongoing grants (75.96 million RMB) as of 2019 | klpb.ibcas.ac.cn |
| Publications | Publishes 7 scientific journals; KLPB/CAS published 22 articles in international journals in 2019 | english.ib.cas.cn · klpb.ibcas.ac.cn |
| Principal staff | Rongcheng Lin (KLPB director), Jindong Zhao (academic committee chair), Wang Wenda, Tian Lijin, Liu Xiaojuan | english.ib.cas.cn · klpb.ibcas.ac.cn |
| Headcount | 44 staff in the Key Laboratory of Photobiology (as of 2019) | klpb.ibcas.ac.cn |
Independent sources: english.ib.cas.cn · ib.cas.cn · klpb.ibcas.ac.cn
Technologies
| Name | Cluster | Risk | |
|---|---|---|---|
| Engineered photosynthesis and artificial chloroplasts | biofuels-bioenergy | Medium | → |
Compiled by BIOECON from primary sources.
Compliance
Bioecon is an information intermediary; it is not a regulator, a certification body, or a legal advisor. When working with public-sector customers (procurement under 44-FZ / 223-FZ), Bioecon acts solely as an independent analytical platform, with no remuneration from suppliers.